Furthermore, some data support the hypothesis that there could be an interplay between KRAS epigenetic regulation and lung cancer pathogenesis (141), suggesting a sophisticated balance between genomic and epigenomic features and lung cancer development. This evidence concerns the gene KRAS and lung carcinoma.